ArticleJAMA oncology2021

Durability of Response to SARS-CoV-2 BNT162b2 Vaccination in Patients on Active Anticancer Treatment.

Noa Eliakim-Raz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.